Radiant Innovation

Radiant Innovation EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -161.21. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 120.94 — a change of -233.30% (lower).

EV/FCF

-161.21

YoY

-233.30%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Radiant Innovation is 2025 -161.21 . EV/FCF (Enterprise Value to Free Cash Flow) of Radiant Innovation was 2024 120.94 . It decreases by -233.30% lower compared to the previous year.

The Radiant Innovation EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
223.73 TWD
Jan 1, 2019
13.33 TWD
Jan 1, 2020
1.13 TWD
Jan 1, 2021
-5.55 TWD
Jan 1, 2022
-19.13 TWD
Jan 1, 2023
-173.31 TWD
Jan 1, 2024
120.94 TWD
Jan 1, 2025
-161.21 TWD
The Radiant Innovation EV/FCF history
YEAREV/FCFYoY
-161.21-233.30%
120.94-169.78%
-173.31+805.97%
-19.13+244.50%
-5.55-591.17%
1.13-91.52%
13.33-94.04%
223.73-1,116.15%
-22.02-338.52%
9.23-203.60%
-8.91-40.47%
-14.97—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

EV/FCF (Enterprise Value to Free Cash Flow) of Radiant Innovation is -161.21 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Radiant Innovation changed from 120.94 to -161.21, representing a -233.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Radiant Innovation

All Key Metrics — Radiant Innovation